Literature DB >> 29569087

Reversal of retinal pigment epithelial detachment after cessation of topical travoprost therapy.

Venkataramana Kalikivayi1, Jerry Joseph2, Blessy Thankom Mathews2, Rajkumar Maheswari2, Satyajit Mulanjur Vadakara2, Sajeev Cherian Jacob2.   

Abstract

PURPOSE: To report the rare incidence of retinal pigment epithelial detachment (RPED) followed by topical travoprost therapy and its subsequent reattachment after cessation of the drug.
METHODS: A 60-year-old male presented with gradual loss of vision in both eyes and distorted images in right eye. He gave a history of visiting an ophthalmologist a week ago for a routine eye examination. His previous reports revealed best-corrected visual acuity (BCVA) of 6/6, N6 in both eyes with raised intraocular pressures. A diagnosis of primary open-angle glaucoma was made and prescribed topical travoprost 0.004% eye drops. This patient's subsequent visit with diagnosis and treatment is mentioned in this case report.
RESULTS: On examination, his BCVA was found to be 6/36, N12 and 6/6, N6 in right and left eyes, respectively. Optical coherence tomography (OCT) macular scan revealed RPED involving fovea in the right eye and inferotemporal to fovea in the left eye. Patient was advised to discontinue topical travoprost and started brinzolamide 1% eye drops. Ten-day follow-up visit revealed partially resolved RPED by OCT with 6/9 and 6/6 visual acuity in the right and left eyes, respectively. After 1 month, reversal of RPED was noted in OCT with 6/6 vision in both eyes.
CONCLUSION: Hence, clinicians should be aware of this rare incidence of RPED followed by travoprost therapy. First case of RPED following travoprost therapy and complete reattachment upon withdrawal is reported here in this case report.

Entities:  

Keywords:  Intraocular pressure; Prostaglandin analogues; Retinal pigment epithelial detachment; Travoprost

Mesh:

Substances:

Year:  2018        PMID: 29569087     DOI: 10.1007/s10792-017-0711-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  12 in total

1.  Optical coherence tomography characterisation of idiopathic central serous chorioretinopathy.

Authors:  J A Montero; J M Ruiz-Moreno
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

Review 2.  Side effects associated with prostaglandin analog therapy.

Authors:  Albert Alm; Ian Grierson; M Bruce Shields
Journal:  Surv Ophthalmol       Date:  2008-11       Impact factor: 6.048

3.  Retinal pigment epithelial detachments in the elderly: classification and outcome.

Authors:  A G Casswell; D Kohen; A C Bird
Journal:  Br J Ophthalmol       Date:  1985-06       Impact factor: 4.638

Review 4.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

5.  An adenosine agonist and prostaglandin E1 cause breakdown of the blood-retinal barrier by opening tight junctions between vascular endothelial cells.

Authors:  S A Vinores; H Sen; P A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-05       Impact factor: 4.799

6.  Central serous chorioretinopathy associated with topical latanoprost therapy.

Authors:  Ozgur Artunay; Amber Senel; Alper Sengul; Rifat Rasier; Halil Bahcecioglu
Journal:  Ocul Immunol Inflamm       Date:  2011-12       Impact factor: 3.070

Review 7.  The role of carbonic anhydrase inhibitors in the management of macular edema.

Authors:  T J Wolfensberger
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

8.  Recurrent serous macular detachment after topical ocular hypotensive medication.

Authors:  Eulogio Besada; Diana Shechtman; Barry J Frauens
Journal:  Clin Exp Optom       Date:  2008-06-05       Impact factor: 2.742

9.  New hypotheses on the pathogenesis and treatment of serous retinal detachment.

Authors:  M F Marmor
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

10.  Dorzolamide chlorhydrate versus acetazolamide in the management of chronic macular edema in patients with retinitis pigmentosa: description of three case reports.

Authors:  Elena Pacella; Loredana Arrico; Valentina Santamaria; Paolo Turchetti; Maria Rosaria Carbotti; Giuseppe La Torre; Fernanda Pacella
Journal:  Ophthalmol Eye Dis       Date:  2014-05-27
View more
  1 in total

1.  Iridocorneal Endothelial Syndrome with Coexisting Macular Edema and Neurosensory Detachment: An Unusual Case Report.

Authors:  Suneeta Dubey; Kanika Jain; Shalini Singh; Saptarishi Mukhejee
Journal:  J Curr Glaucoma Pract       Date:  2021 Sep-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.